Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€62.50
Target price
20.06.25
€67.14
Performance (%)
6.40%
Price
03.09.24
€69.50
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 6.40%. This prediction currently runs until 20.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | 0.000% | 0.000% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat